Clinical Trial Update: A Study to Learn More About How Safe Nurandociguat is and How it Affects the Way the Body Processes Rosuvastatin and Dabigatran in Healthy Adults [Phase 1]

View source ↗

Summary

Phase 1 study evaluating safety and how Nurandociguat affects the body's processing of rosuvastatin and dabigatran in healthy adults, with chronic kidney diseas…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• Dabigatran (Dabigatran etexilate)
• Nurandociguat (nurandociguat)
• Rosuvastatin (rosuvastatin)

Snippet

Sponsor: Bayer | Conditions: Chronic Kidney Disease | Phase 1 | Status: NOT_YET_RECRUITING